CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma.

Frey, Lisa; Klümper, Niklas; Schmidt, Doris; Kristiansen, Glen; Toma, Marieta; Ritter, Manuel; Alajati, Abdullah; Ellinger, Jörg

Frey, Lisa; Klümper, Niklas; Schmidt, Doris; Kristiansen, Glen; Toma, Marieta; Ritter, Manuel; Alajati, Abdullah; Ellinger, Jörg.

Afiliación

Frey L; Department of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Klümper N; Department of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Schmidt D; Department of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Kristiansen G; Institute of Pathology, University Hospital Bonn, 53127 Bonn, Germany.
Toma M; Institute of Pathology, University Hospital Bonn, 53127 Bonn, Germany.
Ritter M; Department of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Alajati A; Department of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Ellinger J; Department of Urology, University Hospital Bonn, 53127 Bonn, Germany.

Cancers (Basel) ; 13(9)2021 Apr 30.

Article en En | MEDLINE | ID: mdl-33946584

Palabras clave

biomarker; circEGLN3; circEHD2; circNETO2; circular RNA; renal cell carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google